Ubiquitin-like protein fat10 protects cardiac myocytes against apoptosis

K. Hong,Y. Shen,J. H. Shao,X. G. P. Peng,Q. Cao,W. F. He,X. Yu,X. X. Liu,A. J. Marian
DOI: https://doi.org/10.1093/eurheartj/eht309.p3279
IF: 39.3
2013-01-01
European Heart Journal
Abstract:Purpose: FAT10 is a recently identified member of the ubiquitin-like protein family with yet-to-be defined biological functions in the heart. Our study is to determine the role of FAT10 in cardiac myocyte apoptosis. Methods and results: FAT10 is expressed in normal human and murine hearts, as detected by qPCR and Western blotting. Expression of FAT10 is increased in the heart at the border zone of myocardial infarction and in cultured Neonatal Rat Cardiac Myocytes (NRCM) subjected to Hypoxia/Reoxygenation (H/R) stress. Lentiviral-mediated overexpression of FAT10 in NRCM is associated with reduced apoptosis, detected by FACS analysis of annexin-V expression and TUNEL assay, in response to H/R injury. Expression of FAT10 was associated with reduced expression of p53 and abrogation of H/R-induced p53 expression. Concordant with reduced p53 level, miR-34a level, which is regulated by p53, was also reduced. Likewise, expression of FAT10 was associated with increased level of anti-apoptotic protein BCL-2, which is a downstream target of miR-34a. It also abrogated H/R-induced expression of pro-apoptotic protein BAX, leading to a favorable shift in the BCL2/BAX ratio against apoptosis. Treatment of NRCM with proteasome inhibitor MG132 increased p53 and miR-34a levels and reduced BLC2/BAX ratio. These changes were reversed upon over-expression of FAT10 in NRCM. Conclusions: Expression of FAT10 is upregulated in the heart and NRCM in response to H/R stress. Upregulation of FAT10 protects cardiac myocytes against apoptosis by suppressing p53, probably through fatylation and proteasomal degradation, and miR-34a expression, which shifts the BCL2/BAX proteins against apoptosis. Thus, FAT10 is a cardioprotective gene.
What problem does this paper attempt to address?